Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - AM-Pharma BV

May 12, 2015
Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company
Option may be exercised based on Phase II trial results for recombinant human Alkaline Phosphatase. More

September 11, 2014
AM-Pharma Closes €12.2m Financing Round
New capital to complete Phase II development of recAP in Acute Kidney Injury. More

September 23, 2013
AM-Pharma returns to clinic with Phase I trial of new recombinant human Alkaline Phosphatase
AM-Pharma returns to clinic with Phase I trial of new recombinant human Alkaline Phosphatase to treat Acute Kidney Injury. More

December 17, 2009
AM-Pharma announces positive results from its Acute Kidney Injury trial
Positive Phase II trial results confirm observations from earlier Acute Kidney Injury trial. More

March 19, 2009
AM-Pharma announces loan of up to €5 million from Dutch Government
Dutch Government supports AM-Pharma in development of first drug against Acute Kidney Injury More

July 9, 2008
AM-Pharma announces start of second Phase II trial in Acute Renal Failure
Additional Phase II trial aims to confirm earlier positive results More

May 29, 2008
AM-Pharma announces EURO 7 million first close of series C financing round
AM-Pharma B.V., the biopharmaceutical company developing improved endogenous proteins and peptides to combat disease, today announced the signing of a EURO 7 million financing agreement with Forbion Capital Partners and Inventages Venture Capital.
More

September 17, 2007
AM-Pharma announces appointment of Chief Business Officer
AM-Pharma B.V., the biopharmaceutical company developing improved endogenous proteins to combat disease, today announced the appointment of Erik van den Berg as Chief Business Officer. More

August 6, 2007
AM-Pharma announces 2.5 million EURO financing
AM-Pharma B.V., the biopharmaceutical company developing improved endogenous proteins to combat disease, today announced the signing of a 2.5 million Euro financing agreement with its two main investors, Forbion Capital Partners and Inventages Venture Capital. More

July 9, 2007
AM-Pharma announces positive results of Phase IIa clinical trial with Alkaline Phosphatase
AM-Pharma, the biopharmaceutical company developing novel therapeutics to treat infectious and inflammatory diseases, today announced the positive clinical results of its Phase IIa Alkaline Phosphatase trial for patients with ulcerative colitis, a chronic and relapsing inflammatory bowel disease affecting the colon. More

Data


26,126
Tech investments
From our Online Data Service
16,881
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices
Sep 12€9.0MSoftware development

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.